This forum is for questions about medical issues and research aspects of
Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new
Hepatitis Social/Living with Hepatitis forum
good luck
Bug
thanks so much...I am geno 1a, just did 4th injection on friday (4/06/07)
Good luck
Bug
I found this quickly but it may be relevant:
"Jensen and colleagues examined data from a large, randomized, phase III study that treated patients infected with HCV genotype 1 with standard and low-dose therapy for 24 or 48 weeks to determine if those who achieved an SVR after 24 weeks of treatment could be identified by an RVR at Week 4. Patients with an RVR had a higher rate of SVR, regardless of treatment group. The data also suggest that there was no difference between SVR rates in patients with RVR when 24 and 48 weeks of therapy were compared. Furthermore, for patients who did not achieve RVR, SVR rates increased as the duration of therapy and the ribavirin dose increased."
I think it is pretty well established that a patient's 4 week response to treatment is highly predictive of the likelihood of achieving SVR. I just don't understand why any knowledgeable practitioner would be reluctant to test VL at 4 weeks with the most sensitive test available.
Mike
http://clinicaloptions.com/Hepatitis/Annual%20Updates/2006%20Annual%20Update/Modules/Sulkowski/Pages/Page%207.aspx
"Taken together, these studies suggest that the current standard of care—monitoring HCV RNA at 12 and 24 weeks—is not sufficient to guide treatment decisions during treatment with peginterferon and ribavirin. Increasingly, strategies that emphasize early monitoring of viral response are being incorporated into clinical care to improve treatment outcomes and limit exposure to therapy that has a low chance of success based on patient or viral characteristics. Current treatment guidelines include consideration of early (Week 12) identification of treatment failure (< 2 log10 decline in HCV RNA from baseline), which can justify treatment discontinuation to limit toxicity and cost for these patients who are not likely to have a virologic response. A more recent development is the use of early viral RNA level at Week 4 of treatment to determine the probability of viral relapse, which may further refine the use of early virologic response monitoring as an effective guide for identifying the optimal duration of a treatment regimen.[9] Emerging data suggest that some patients with rapid viral response (eg, HCV RNA undetectable at Week 4) may be able to shorten their course of treatment, whereas others without complete suppression of hepatitis C replication (HCV RNA detectable at Week 12) may benefit from extending the course of treatment.[10] Future HCV treatment guidelines will need to incorporate these data on individualized treatment duration to improve outcomes with current therapies."
Mike
- Jim
-- Jim
He is using old info if he doesn't recommend you PCR test at week 4 of treatment! I'd get in there and get that lab slip for the PCR DNA test.
I'd take the info. MikeSimon gave you to him or fax it to him or have him review the info at clinicaloptions.com. You need to know if you are RVR(rapid viral responder) if you are, and you are Undetectable at week 4, your chances of clearing the virus and obtaining SVR improve.